Trials / Completed
CompletedNCT01391624
Study on the Possible Effects of Diet Supplementation With Essential Fatty Acids in Chocolate Craving Volunteers
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Federal University of São Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether essential polyunsaturated acids (omega 3) are capable of reducing chocolate craving symptoms in healthy patients. Our hypothesis is that the omega 3 fatty acids have properties which stabilize and normalize neuronal functioning in many conditions, including chocolate craving.
Detailed description
Polyunsaturated fatty acids (of the omega 3 subtype) are fundamental in human diet, as they are components of cellular membranes, guaranteeing their fluidity and their functions of separating intracellular and extracellular means and transporting several substances to and from cellular microenvironment. Modern theories profess that lack of omega 3 fatty acids in western diets may be the cause of several deletery changes in neuronal physiology, which may cause or make worse several pathological conditions, such as depression, mood instability, and drug craving. The role of serotonin as the main lacking component in the conditions is well documented, and it is thought that omega 3 is important in the synthesis, transportation, and ultimately the activity of this neurotransmitter. Out theory states that supplementation with these acids can restore normal neuron balance, improving the condition of chocolate craving patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flaxseed oil | 3 g (3 capsules/day) of flax oil for a period of 8 weeks |
| DRUG | Paraffin + # 2 dye | 3 capsules of mineral oil (ineffective) for 8 weeks. |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2011-07-12
- Last updated
- 2011-07-12
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01391624. Inclusion in this directory is not an endorsement.